248 related articles for article (PubMed ID: 27391980)
21. Decreased natural killer cells in diffuse intrinsic pontine glioma patients.
Zhang L; Yu H; Xue Y; Liu Y
Childs Nerv Syst; 2020 Jul; 36(7):1345-1346. PubMed ID: 32418048
[TBL] [Abstract][Full Text] [Related]
22. The intersect of neurosurgery with diffuse intrinsic pontine glioma.
Kuzan-Fischer CM; Souweidane MM
J Neurosurg Pediatr; 2019 Dec; 24(6):611-621. PubMed ID: 31786541
[TBL] [Abstract][Full Text] [Related]
23. PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma.
Mueller S; Kline C; Stoller S; Lundy S; Christopher L; Reddy AT; Banerjee A; Cooney TM; Raber S; Hoffman C; Luks T; Wembacher-Schroeder E; Lummel N; Zhang Y; Bonner ER; Nazarian J; Molinaro AM; Prados M; Villanueva-Meyer JE; Gupta N
Neuro Oncol; 2023 Nov; 25(11):2074-2086. PubMed ID: 37318058
[TBL] [Abstract][Full Text] [Related]
24. A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.
Veldhuijzen van Zanten SE; Jansen MH; Sanchez Aliaga E; van Vuurden DG; Vandertop WP; Kaspers GJ
Expert Rev Anticancer Ther; 2015 Feb; 15(2):157-64. PubMed ID: 25435089
[TBL] [Abstract][Full Text] [Related]
25. Measurable Supratentorial White Matter Volume Changes in Patients with Diffuse Intrinsic Pontine Glioma Treated with an Anti-Vascular Endothelial Growth Factor Agent, Steroids, and Radiation.
Svolos P; Reddick WE; Edwards A; Sykes A; Li Y; Glass JO; Patay Z
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1235-1241. PubMed ID: 28428205
[TBL] [Abstract][Full Text] [Related]
26. Evaluating infusate parameters for direct drug delivery to the brainstem: a comparative study of convection-enhanced delivery versus osmotic pump delivery.
Rechberger JS; Power EA; Lu VM; Zhang L; Sarkaria JN; Daniels DJ
Neurosurg Focus; 2020 Jan; 48(1):E2. PubMed ID: 31896090
[TBL] [Abstract][Full Text] [Related]
27. Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.
Sewing AC; Caretti V; Lagerweij T; Schellen P; Jansen MH; van Vuurden DG; Idema S; Molthoff CF; Vandertop WP; Kaspers GJ; Noske DP; Hulleman E
J Neurosci Methods; 2014 Dec; 238():88-94. PubMed ID: 25263805
[TBL] [Abstract][Full Text] [Related]
28. Treatment-Related Noncontiguous Radiologic Changes in Children With Diffuse Intrinsic Pontine Glioma Treated With Expanded Irradiation Fields and Antiangiogenic Therapy.
Patay Z; Merchant TE; Nguyen R; Pierson CR; Onar-Thomas A; Broniscer A
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1295-1305. PubMed ID: 29165288
[TBL] [Abstract][Full Text] [Related]
29. Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study.
Fleischhack G; Massimino M; Warmuth-Metz M; Khuhlaeva E; Janssen G; Graf N; Rutkowski S; Beilken A; Schmid I; Biassoni V; Gorelishev SK; Kramm C; Reinhard H; Schlegel PG; Kortmann RD; Reuter D; Bach F; Iznaga-Escobar NE; Bode U
J Neurooncol; 2019 May; 143(1):107-113. PubMed ID: 30830679
[TBL] [Abstract][Full Text] [Related]
30. The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease.
Baugh J; Bartels U; Leach J; Jones B; Chaney B; Warren KE; Kirkendall J; Doughman R; Hawkins C; Miles L; Fuller C; Hassall T; Bouffet E; Lane A; Hargrave D; Grill J; Hoffman LM; Jones C; Towbin A; Savage SA; Monje M; Li XN; Ziegler DS; Veldhuijzen van Zanten S; Kramm CM; van Vuurden DG; Fouladi M
J Neurooncol; 2017 Apr; 132(2):323-331. PubMed ID: 28093680
[TBL] [Abstract][Full Text] [Related]
31. External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry.
Veldhuijzen van Zanten SEM; Lane A; Heymans MW; Baugh J; Chaney B; Hoffman LM; Doughman R; Jansen MHA; Sanchez E; Vandertop WP; Kaspers GJL; van Vuurden DG; Fouladi M; Jones BV; Leach J
J Neurooncol; 2017 Aug; 134(1):231-240. PubMed ID: 28560664
[TBL] [Abstract][Full Text] [Related]
32. ABC Transporter Inhibition Plus Dexamethasone Enhances the Efficacy of Convection Enhanced Delivery in H3.3K27M Mutant Diffuse Intrinsic Pontine Glioma.
Tsvankin V; Hashizume R; Katagi H; Herndon JE; Lascola C; Venkatraman TN; Picard D; Burrus B; Becher OJ; Thompson EM
Neurosurgery; 2020 May; 86(5):742-751. PubMed ID: 31225627
[TBL] [Abstract][Full Text] [Related]
33. Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.
Vajapeyam S; Brown D; Billups C; Patay Z; Vezina G; Shiroishi MS; Law M; Baxter P; Onar-Thomas A; Fangusaro JR; Dunkel IJ; Poussaint TY
AJNR Am J Neuroradiol; 2020 Apr; 41(4):718-724. PubMed ID: 32241771
[TBL] [Abstract][Full Text] [Related]
34. Measuring Tumor Metabolism in Pediatric Diffuse Intrinsic Pontine Glioma Using Hyperpolarized Carbon-13 MR Metabolic Imaging.
Autry AW; Hashizume R; James CD; Larson PEZ; Vigneron DB; Park I
Contrast Media Mol Imaging; 2018; 2018():3215658. PubMed ID: 30174560
[TBL] [Abstract][Full Text] [Related]
35. A Novel Methodology for Applying Multivoxel MR Spectroscopy to Evaluate Convection-Enhanced Drug Delivery in Diffuse Intrinsic Pontine Gliomas.
Guisado DI; Singh R; Minkowitz S; Zhou Z; Haque S; Peck KK; Young RJ; Tsiouris AJ; Souweidane MM; Thakur SB
AJNR Am J Neuroradiol; 2016 Jul; 37(7):1367-73. PubMed ID: 26939629
[TBL] [Abstract][Full Text] [Related]
36. A combined approach of convection-enhanced delivery of peptide nanofiber reservoir to prolong local DM1 retention for diffuse intrinsic pontine glioma treatment.
Bellat V; Alcaina Y; Tung CH; Ting R; Michel AO; Souweidane M; Law B
Neuro Oncol; 2020 Oct; 22(10):1495-1504. PubMed ID: 32301996
[TBL] [Abstract][Full Text] [Related]
37. Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment.
Zhou Z; Singh R; Souweidane MM
Curr Neuropharmacol; 2017; 15(1):116-128. PubMed ID: 27306036
[TBL] [Abstract][Full Text] [Related]
38. Interpretation of magnetic resonance images in diffuse intrinsic pontine glioma: a survey of pediatric neurosurgeons.
Hankinson TC; Campagna EJ; Foreman NK; Handler MH
J Neurosurg Pediatr; 2011 Jul; 8(1):97-102. PubMed ID: 21721895
[TBL] [Abstract][Full Text] [Related]
39. Citrate concentrations increase with hypoperfusion in pediatric diffuse intrinsic pontine glioma.
Yeom KW; Lober RM; Nelson MD; Panigrahy A; Blüml S
J Neurooncol; 2015 Apr; 122(2):383-9. PubMed ID: 25670389
[TBL] [Abstract][Full Text] [Related]
40. Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey.
Veldhuijzen van Zanten SE; van Meerwijk CL; Jansen MH; Twisk JW; Anderson AK; Coombes L; Breen M; Hargrave OJ; Hemsley J; Craig F; Cruz O; Kaspers GJ; van Vuurden DG; Hargrave DR;
Neuro Oncol; 2016 Apr; 18(4):582-8. PubMed ID: 26459800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]